Breaking News, Collaborations & Alliances, Trials & Filings

Trials & Filings in Brief: Dec. 18, 2013

Andromeda Biotech, Banner Pharmacaps, Bayer Healthcare, Genmab, Gilead, GlaxoSmithKline, Ipsen, Lonza, Mylan, Octapharma, Omeros, Regeneron, Versartis

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Phase II Octapharma begins enrolling MS patients . . . read more Phase III Andromeda begins dosing in diabetes extension trial . . . read more Gilead posts SOF/LDV SVR12 results . . . read more Filings Eylea sBLA accepted by FDA . . . read more GSK, Genmab sBLA for Arzerra in CLL gets priority review . . . read more Ipsen files to resupply Increlex in EU . . . read more Mylan, Banner reach Targretin settlement with Eisai, Valeant . . . read more Omeros receives Orphan Designation for TMA ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters